Open access
128
Views
5
CrossRef citations to date
0
Altmetric
Perspectives
Integrating risk minimization planning throughout the clinical development and commercialization lifecycle: an opinion on how drug development could be improved
Elaine H Morrato1 Colorado School of Public Health, University of Colorado, Anschutz Medical Campus, Aurora, CO, USACorrespondence[email protected]
& Meredith Y Smith2 EMD Serono, Inc, Rockland, MA, USA
Pages 339-348
|
Published online: 26 Feb 2015
Reprints and Permissions
Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.
To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.
For more information please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.